Study Links GLP-1 Medications to Increased Incidence of Fainting and Dizziness
Northwestern Medicine researchers have uncovered a significant safety concern linked to glucagon-like peptide-1 receptor agonists (GLP-1s), a widely prescribed class of drugs primarily used for...
















